Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 0 | 0 | 0 | 0 | 235 |
| Gross Profit | N/A | N/A | N/A | N/A | 235 |
| Operating Expenses | 15,773 | 15,820 | 18,143 | 17,315 | 16,871 |
| Operating Income | -15,773 | -15,820 | -18,143 | -17,315 | -16,636 |
| Other Income | 892 | 852 | 882 | 1,009 | 1,149 |
| Pre-tax Income | -14,881 | -14,968 | -17,261 | -16,306 | -15,487 |
| Net Income Continuous | -14,881 | -14,968 | -17,261 | -16,306 | -15,487 |
| Minority Interests | 1 | 3 | 2 | N/A | -4 |
| Net Income | $-14,881 | $-14,975 | $-17,259 | $-16,306 | $-15,483 |
| EPS Basic Total Ops | -0.17 | -0.17 | -0.23 | -0.23 | -0.23 |
| EPS Basic Continuous Ops | -0.17 | -0.17 | -0.23 | -0.23 | -0.23 |
| EPS Diluted Total Ops | -0.17 | -0.17 | -0.23 | -0.23 | -0.23 |
| EPS Diluted Continuous Ops | -0.17 | -0.17 | -0.23 | -0.23 | -0.23 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.18 | -0.23 | N/A | N/A |
| EBITDA(a) | $-15,913 | $-16,371 | $-18,364 | $-17,667 | $-16,677 |